Ips - Clinolipid
Payments companies reported to CMS as associated with Ips - Clinolipid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ips - Clinolipid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ips - Clinolipid
These are the largest totals companies reported as associated with Ips - Clinolipid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thea Price | Jacksonville, FL | Surgery | $8,160.00 |
| Cynthia Blanco | San Antonio, TX | Neonatal-Perinatal Medicine | $3,400.00 |
| Kara Calkins | Los Angeles, CA | Pediatrics | $2,680.67 |
| Camilia Martin | Ny, NY | Neonatal-Perinatal Medicine | $2,202.97 |
| Smyrna Rivera | Indianapolis, IN | Family | $55.12 |
| Elizabeth Castle | Boston, MA | Pediatrics (Nurse Practitioner) | $24.72 |
| Jennifer Mcclelland | Boston, MA | Family | $24.72 |
Prescribed Ips - Clinolipid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.